Objective: To establish a rapid,accurate and simultaneous quantitative analysis method for probe drugs of major cytochrome P450(CYP450) enzymes and their specific metabolites,in order to be used in clinical evaluation of drug-drug interaction(DDI). Methods: A“ probe cocktail” approach was employed to evaluate the activities of CYP450s composed of caffeine(CYP1A2),losartan(CYP2C19),omeprazole(CYP2C9), dextromethorphan(CYP2D6,CYP3A4) and midazolam(CYP3A4). An online-SPE-LC-MS/MS method was developed to analyze the human plasma after“ probe cocktail” was administrated. Plasma samples were hydrolyzed by glucuronidase and subjected to online solid-phase extraction with Spark HySphere-C18HD(10 mm×2 mm, 7 μm) thereafter. Separation of 11 analytes was accomplished by a gradient elution on a Shiseido MGⅢ(2.0 mm×100 mm,5 μm) analytical column using methanol-acetonitrile(1∶1)-water with 0.01% formic acid as the mobile phase at a flow rate of 0.35 mL·min-1. The column temperature was maintained at 40 ℃ . Mass spectrometry was performed using a triple-quadrupole mass spectrometer operated in positive ion ESI mode, with MS/MS transitions of 5 probe drugs and the corresponding 6 metabolites monitored. Results: The established analysis method could complete the detection of 11 analytes in 5 minutes. The validation of methodology showed that the method had specificity for the analysis of plasma samples,exhibited good linearity in the quantitative ranges and little matrix effect. The RSD values of the intra-and inter-batch quality control samples of the analytes were 2.1%-14.2% at medium and high concentrations and 2.1%-15.4% at LLOQ level along with the accuracy in the range of 86.4% to 107.2%. The samples had good stability at room temperature,long-term freezing,repeated freeze-thaw and placement at autosampler. The method was applied to analyze plasma samples from subjects taken the“ probe cocktail”. The results showed that the concentrations of 5 probe drugs and 6 metabolites were all within the quantitative range. Among them,the concentration of dextromethorphan's metabolite 3-methoxymorphan was the lowest,all of which were lower than 2 ng·mL-1. Conclusion: The established online SPE-LC-MS/MS method provides a rapid and sensitive analytical tool to serve the investigation of multiple DDI and the CYP450 enzymes phenotyping in the clinic.
ZHANG Ying, LI Jun-mei, MIAO Lan, SUN Ming-qian, LIN Li, LIU Jian-xun, XU Li
. Simultaneous determination of 5 probe drugs for CYP450s and their 6 specific metabolites in human plasma by online SPE-LC-MS/MS*[J]. Chinese Journal of Pharmaceutical Analysis, 2021
, 41(4)
: 603
-612
.
DOI: 10.16155/j.0254-1793.2021.04.06
[1] LEE B,JI HK,LEE T,et al.Simultaneous screening of activities of five cytochrome P450 and four uridine 5'-diphosphoglucuronosyltransferase enzymes in human liver microsomes using cocktail incubation and liquid chromatography-tandem mass spectrometry[J].Drug Metab Dispos,2015,43(7):1137
[2] CHEN ZH,ZHANG SX,LONG N,et al.An improved substrate cocktail for assessing direct inhibition and time-dependent inhibition of multiple cytochrome P450s[J].Acta Pharmacol Sin,2016,37(5):708
[3] CDE.药物相互作用研究指导原则[EB/OL].(2012-05-15)[2020-07-12].http://www.cde.org.cn/zdyz.do?method=largePage&id=17f80cb05ff320e3
CDE.Guidence for Drug-drug Interaction Researches[EB/OL]. (2012-05-15)[2020-07-12].http://www.cde.org.cn/zdyz.do?method=largePage&id=17f80cb05ff320e3
[4] CDER.In vitro Metabolism-and Transporter-Mediated Drug-Drug Interaction Studies-Guidance for Industry[EB/OL].(2020-01-23)
[2020-07-16].https://www.fda.gov/media/134582/download.
[5] BREIMER DD.Interindividual variations in drug disposition. Clinical implications and methods of investigation[J].Clin Pharmacokinet,1983,8(5):371
[6] GIRI P,PATEL H,SRINIVAS NR.Use of cocktail probe drugs for indexing cytochrome P450 enzymes in clinical pharmacology studies— Review of case studies[J].Drug Metab Lett,2019,13(1):3
[7] 刘颖,焦建杰,娄建石.“Cocktail”探针药物法的研究进展[J].中国临床药理学与治疗学,2006,11(11):1225
LIU Y,JIAO JJ,LOU JS.Progress of“ Cocktail” probe substrates approaches[J].Chin J Chin Phanrmacol Ther,2006,11(11): 1225
[8] YU A,HAINING RL.Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro:can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?[J].Drug Metab Dispos,2001,29(11):1514
[9] DE ANDRES F,SOSA-MACIAS M,LLERENA A.A rapid and simple LC-MS/MS method for the simultaneous evaluation of CYP1A2,CYP2C9,CYP2C19,CYP2D6 and CYP3A4 hydroxylation capacity[J].Bioanalysis,2014,6(5):683
[10] SCHADEL M,WU D,OTTON SV,et al.Pharmacokinetics of dextromethorphan and metabolites in humans:influence of the CYP2D6 phenotype and quinidine inhibition[J].J Clin Psychopharmacol,1995,15(4):263
[11] HEIZMANN P,ECKERT M,ZIEGLER WH.Pharmacokinetics and bioavailability of midazolam in man[J].Br J Clin Pharmacol, 1983,16(Suppl 1):43S
[12] CHRISTENSEN M,ANDERSSON K,DALEN P,et al.The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes[J].Clin Pharmacol Ther,2003,73(6):517
[13] FRYE RF,MATZKE GR,ADEDOYIN A,et al.Validation of the five-drug“ Pittsburgh cocktail” approach for assessment of selective regulation of drug-metabolizing enzymes[J].Clin Pharmacol Ther, 1997,62(4):365
[14] RYU JY,SONG IS,SUNWOO YE,et al.Development of the“ Inje cocktail” for high-throughput evaluation of five human cytochrome P450 isoforms in vivo[J].Clin Parmacol Ther,2007,82(5):531
[15] ADAWAY JE,KEEVIL BG.Therapeutic drug monitoring and LCMS/ MS[J].J Chromatogr B Analyt Technol Biomed Life Sci,2012, 883-884:33
[16] TANAKA S,UCHIDA S,INUI N,et al.Simultaneous LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 substrate drugs and their metabolites[J].Biol Pharm Bull, 2014,37(1):18